NovaBridge Biosciences (NBP) vs Minerva Neurosciences, Inc (NERV)

NovaBridge Biosciences and Minerva Neurosciences, Inc are both Biotechnology companies. NovaBridge Biosciences and Minerva Neurosciences, Inc are of similar size ($172.8M and $164.7M). Across the 8 metrics below, NovaBridge Biosciences leads on 5 and Minerva Neurosciences, Inc on 3.

Valuation

Metric NBP NERV Biotechnology median
P/E n/m n/m 7.88
P/S 5.81 n/m 11.47
P/B 0.56 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 1.86 n/m 0.74
EV/Sales (3.66) n/m 10.73
Earnings yield (35.25%) (834.41%) (28.84%)
Free cash flow yield (82.02%) (16.59%) (23.03%)

Profitability

Metric NBP NERV Biotechnology median
Gross margin 31.10% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% 322.05% (57.72%)
Return on assets 0.00% (629.71%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NBP NERV Biotechnology median
Revenue growth (TTM) (91.84%) — 5.64%
EPS growth (last fiscal year) (77.78%) (18,347.37%) —
Revenue growth, 5-year CAGR (40.00%) — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NBP NERV Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.64 20.14 4.73
Net debt to EBITDA 2.26 5.46 0.96

Dividend

Metric NBP NERV Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric NBP NERV Biotechnology median
Market cap 172.84m 164.73m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack